0001209191-18-048174.txt : 20180823
0001209191-18-048174.hdr.sgml : 20180823
20180823162820
ACCESSION NUMBER: 0001209191-18-048174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180820
FILED AS OF DATE: 20180823
DATE AS OF CHANGE: 20180823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sze Randoll
CENTRAL INDEX KEY: 0001751011
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 181035056
MAIL ADDRESS:
STREET 1: C/O ATHENEX, INC.
STREET 2: 1001 MAIN STREET, SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-20
0
0001300699
Athenex, Inc.
ATNX
0001751011
Sze Randoll
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
17.09
2018-08-20
4
A
0
90000
0.00
A
2028-08-20
Common Stock
90000
90000
D
Stock Option (Right to Buy)
17.77
2027-10-03
Common Stock
28000
28000
D
Stock Option (Right to Buy)
17.30
2028-03-27
Common Stock
10000
10000
D
The option vests in four equal annual installments beginning on August 20, 2019.
The option vests in four equal annual installments beginning on October 3, 2018.
The option vests in four equal annual installments beginning on March 27, 2019.
/s/Teresa Bair, Attorney-in-Fact
2018-08-23